Table 1.
Demographic characteristics and mean blood parameters of all patients
Variables | Group 1 (ATO) n=20 Mean±SD | Group 2 (ITO) n=25 Mean±SD | Group 3 (Control) n=35 Mean±SD | p | P*** (Groups 1&2) | P*** (Groups 1&3) | P*** (Groups 2&3) |
---|---|---|---|---|---|---|---|
Age (years) | 45.45±13.47 | 41.00±13.70 | 42.60±14.44 | 0.68* | |||
Gender (female/male) | 12:8 | 15:10 | 22:13 | 0.79** | |||
Neutrophil (109/L) | 5.31±2.38 | 4.20±1.39 | 3.99±0.92 | 0.04* | 0.05 | 0.09 | 1.00 |
Lymphocyte (109/L) | 2.51±1.12 | 2.68±0.69 | 2.71±0.56 | 0.01* | 1.00 | 0.01 | 0.37 |
Platelet (109/L) | 289.18±37.94 | 252.69±46.95 | 241.71±70.82 | 0.07* | |||
MPV (fL) | 10.76±0.70 | 9.94±1.39 | 8.19±0.81 | <0.001* | 0.04 | <0.001 | <0.001 |
NLR | 2.11±1.27 | 1.56±0.71 | 1.47±092 | 0.03* | 0.01 | <0.001 | 0.33 |
ATO: Active thyroid ophthalmopathy; ITO: Inactive thyroid ophthalmopathy; MPV: Mean platelet volume; NLR: Neutrophil-to-lymphocyte ratio.
p<0.05 was considered statistically significant;
One-way analysis of variance;
’Bonferroni post-test;
Chi-square test.